AgelessRx markets compounded NAD+ injections alongside other longevity services. Its NAD+ product page puts substantial emphasis on its research program and customer-reported results, which makes understanding the kind of evidence especially important.
We reviewed the public product and offer pages, not a personal course of treatment. This is a document-based assessment of the service, purchasing questions, and evidence boundaries. CoreAge Rx is this site’s featured commercial partner; that relationship does not turn another provider’s claims into established facts or invalidate them.
Research visibility is useful, but surveys and multi-treatment studies should not become promises about a home NAD+ prescription. Confirm the specific plan and billing interval.
The promotional page shows several price points and four-week billing language. We do not present a single verified ongoing price.
Where AgelessRx may fit
Someone who wants to read about a provider’s research interests before arranging care may find AgelessRx’s product information useful. The page connects the offering to a wider longevity program. That is a reason to investigate the program’s actual studies, rather than assume every linked study tested the prescription you would receive.
Ask how a new patient is assessed, which clinician is responsible for follow-up, and how that clinician explains alternatives. A company can offer more than one NAD-related product. Confirm the exact ingredient and route on the plan under discussion so a patch, oral precursor, or injection is not accidentally treated as the same intervention.
Why we do not publish one settled monthly price
The promotional material we found contains multiple displayed price points and language about billing every four weeks. A short introductory offer, a different vial volume, and an ongoing plan can coexist on the same page. Without selecting and confirming a specific plan, collapsing those numbers into one monthly fee could mislead a reader.
Four-week billing also differs from calendar-month billing: a 52-week year contains thirteen four-week periods. Ask for the renewal amount and interval in writing, then calculate the annual commitment. Compare a like-for-like quantity, the allowed use period, consultation costs, and supplies. The cost guide includes a simple framework for doing that.
Customer survey results need context
The product page describes customer-reported outcomes. A survey can tell a service what responding customers say, but it cannot by itself establish what would have happened without treatment. People who continue and answer a follow-up may differ from those who stop, do not respond, or experience little benefit.
When evaluating a percentage, ask about the denominator, missing responses, timing, question wording, and comparison group. Those questions are relevant even when a large number of customers participated. We have not audited the underlying survey data and do not use it to forecast your chance of feeling more energetic or mentally clear.
Research programs are not interchangeable with product trials
A provider’s participation in longevity research does not mean every marketed product has demonstrated the same outcomes. Combination studies can include several treatments and lifestyle changes, making it difficult to isolate the contribution of NAD+. Early safety studies answer narrower questions than long-term effectiveness trials.
Look for the ingredient, formulation, administration route, participant group, comparison, and measured outcome. An IV result does not automatically apply to a subcutaneous prescription. Our evidence guide shows how to read those distinctions, including the limitations of the human IV pilot studies reviewed for this site.
Confirm the pharmacy and practical routine
Ask who compounds your prescription and whether that pharmacy can be contacted directly. Request the actual storage instructions, the beyond-use date, and guidance for a shipment whose temperature is uncertain. A website photograph cannot tell you whether a delivered vial is suitable for use.
Find out how refills work if your prescription changes or you travel. A larger vial can appear cheaper while creating waste if the allowed use period expires before you finish it. Keep the pharmacy’s directions for the dispensed product and obtain clarification whenever the device, concentration, or label changes. Our label-reading guide covers the questions to bring to the pharmacist.
Make ongoing care part of the comparison
Ask when a clinician will review your progress and what symptoms require earlier contact. Clarify the way to cancel, whether cancellation affects a pending shipment, and what charges are nonrefundable. Plan reminders around the actual billing interval, especially if it is every four weeks.
Compare AgelessRx with CoreAge Rx, Eden, and Hone using total cost and follow-up access. No provider earns a clinical advantage here from the number of marketing claims on its homepage. The useful question is whether the provider can give you a clear, individualized explanation of the proposed care and its limitations.
Related questions before an evaluation.
Review home-injection responsibilities, dosing-label questions, and how to assess results before committing to a program. If you are comparing with a store-bought option, oral supplements have different ingredients, evidence, and costs.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- AgelessRx: NAD+ Injection Provider product page. Customer surveys are not controlled clinical trials.
- AgelessRx: NAD+ offer and billing terms Promotional page contains multiple prices; verify selected plan and renewal.
- Grant et al. (2019): NAD+ infusion metabolome pilot Small human IV study; metabolic observations do not prove longevity or everyday benefits.
- Reyna et al. (2026): retrospective IV tolerability pilot Route-specific retrospective tolerability evidence; not proof of effectiveness for home injections.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.